Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
514.00    -4.00 (-0.77%)
Bid:
512.00
Ask:
514.00
Spread: 2.00 (0.391%)
Market Cap: £295.77m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Statement

22 May 2024 07:00

RNS Number : 3902P
Mortgage Advice Bureau (Hldgs) PLC
22 May 2024
Β 

22 May 2024

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 1pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"New mortgage applications in the market have been better year to date compared to the equivalent period last year. All purchase-related activity has picked up, including a welcome recovery in Buy-to-Let, whilst re-mortgaging is slightly down versus last year. This reflects a reduced number of borrowers needing to re-finance during the period, plus a greater proportion of those that have re-financed selecting Product Transfers instead. MAB has performed well in these conditions.

"In terms of completions, as expected, the wider market was slow in Q1 2024, having carried a low pipeline into this year. This resulted in a 13% reduction in new mortgage lending2 for Q1 2024 compared to the prior year. Despite these slower market conditions, we have continued to grow our market share, with MAB's total mortgage completions for Q1 2024 broadly stable at Β£5.7bn (2023: Β£5.8bn). This has been achieved, in part, through increased productivity across our adviser base. Our new mortgage completions were Β£4.1bn (2023: Β£4.4bn) with the balance of Β£1.6bn (2023: Β£1.4bn) being Product Transfers.

"On 17 May 2024, our mainstream Adviser numbers were 1,906 (31 December 2023: 1,918) and our total1 number of Advisers was 2,110 (31 December 2023: 2,158). The momentum in our new Appointed Representative ("AR") recruitment activity continues to be strong, and consequently we expect a high number of new firms and advisers to join MAB over the next few months. Our pipeline of incoming new ARs has also continued to grow strongly over the last few months. This momentum has built as a direct result of the significant developments in technology and lead generation that we have delivered, as well as further investment in our recruitment resources to ensure we can capitalise on the opportunity our proposition enhancements bring.

"We expect our existing AR firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty.

"MAB's performance, even though mortgage activity as a result of the subdued market conditions remains below long-term averages, is in line with the Board's expectations, with further improvement expected in the second half of this year. I am therefore delighted to be leaving MAB in excellent shape as I hand over to Mike Jones who will succeed me as Chair with effect from today. "

Peter Brodnicki, Chief Executive Officer, commented:

"Our performance once again demonstrates MAB's ability to continue winning market share in all market conditions. I would like to take this opportunity to thank Katherine for her excellent contribution since IPO. It has been an absolute pleasure working with her, and she leaves the business in fantastic shape.

I would also like to take this opportunity to welcome Emilie McCarthy3 as our new Chief Financial Officer, replacing Lucy Tilley. I congratulate Lucy and thank her for her outstanding contribution to MAB since she joined in 2015. We wish her every success in the future."

1 Includes a total of 204 advisers at 17 May 2024 who are advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB. MAB's Later life advisers are now dual authorised and hence are included in the mainstream number.

2 UK Finance, product transfer lending figures not available until early June.

3 Emilie McCarthy was appointed as a Director of the Single Homeless Project on 15 May 2024.

Β 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

Β 

Peter BrodnickiΒ - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

Β 

Nominated Adviser and Joint Broker:

Deutsche Numis

Stephen Westgate / Giles Rolls

Β 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson / Rob Parker

Β 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMSEFEDFELSEFI
Date   Source Headline
17th Oct 20187:00 amRNSReplacement: Director/PDMR Shareholding
16th Oct 20187:00 amRNSDirector/PDMR Shareholding
4th Oct 20182:24 pmRNSHolding(s) in Company
4th Oct 20188:11 amRNSHolding(s) in Company
28th Sep 20182:16 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSHalf-year Report
14th Sep 20184:43 pmRNSDirector/PDMR Shareholding
14th Sep 20187:00 amRNSChange of Adviser
31st Aug 201811:08 amRNSDirector/PDMR Shareholding
28th Aug 20184:10 pmRNSHolding(s) in Company
14th Aug 20183:13 pmRNSDirector/PDMR Shareholding
2nd Aug 201812:07 pmRNSSecond Price Monitoring Extn
2nd Aug 201812:02 pmRNSPrice Monitoring Extension
31st Jul 20185:05 pmRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSPre-close Trading Update
16th Jul 20182:34 pmRNSDirector/PDMR Shareholding
2nd Jul 20186:43 pmRNSHolding(s) in Company
2nd Jul 20186:43 pmRNSHolding(s) in Company
29th Jun 20185:06 pmRNSDirector/PDMR Shareholding
14th Jun 20185:28 pmRNSDirector/PDMR Shareholding
7th Jun 20187:00 amRNSBoard Appointment
31st May 20186:16 pmRNSDirector/PDMR Shareholding
23rd May 20184:08 pmRNSDirector/PDMR Shareholding
17th May 20183:10 pmRNSResult of AGM
17th May 201810:31 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSAGM Statement
15th May 20187:00 amRNSDirector/PDMR Shareholding
30th Apr 20184:34 pmRNSDirector/PDMR Shareholding
17th Apr 20182:08 pmRNSPosting of Report and Accounts & Notice of AGM
16th Apr 20183:49 pmRNSDirector/PDMR Shareholding
10th Apr 20186:20 pmRNSGrant of options and Director dealing
6th Apr 20187:00 amRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSBoard Appointment
29th Mar 20183:23 pmRNSDirector/PDMR Shareholding
28th Mar 20187:26 amRNSBlock Admission Application
20th Mar 20187:00 amRNSFinal Results for the year ended 31 December 2017
15th Mar 20189:38 amRNSDirector/PDMR Shareholding
28th Feb 20184:00 pmRNSDirector/PDMR Shareholding
15th Feb 20188:07 amRNSDirector/PDMR Shareholding
31st Jan 20186:15 pmRNSDirector/PDMR Shareholding
22nd Jan 20187:00 amRNSPre-close Trading Update
15th Jan 20183:31 pmRNSDirector/PDMR Shareholding
8th Jan 20188:56 amRNSNon-Executive Director Board changes
28th Dec 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20175:59 pmRNSDirector/PDMR Shareholding
30th Nov 20174:23 pmRNSDirector/PDMR Shareholding
14th Nov 20174:31 pmRNSDirector/PDMR Shareholding
13th Nov 201711:21 amRNSHolding(s) in Company
31st Oct 20176:24 pmRNSDirector/PDMR Shareholding
16th Oct 20174:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.